Month: January 2026

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) today announced the planned expansion of its HealthTab™ platform across North East London (NEL), with deployment to an additional 70 community pharmacy sites, building on the success of its NHS-linked cardiovascular programmes delivered in collaboration with Barts Health NHS Trust. The programme has attracted national attention, including recent coverage by BBC News highlighting the growing role of community pharmacies in delivering cardiovascular care. The additional sites are expected to be deployed in the coming weeks, reflecting strong pharmacy engagement, increasing clinical demand, and alignment with NHS priorities to shift more care from hospital settings into the community. “This...

— Four new paper and packaging satellites in China and India; doubled capacity at an additional site in India — — 50% of Asia expansions dedicated to packaging applications — NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) (“MTI”), a leading, technology-driven specialty minerals company, today announced an expansion of its paper and packaging business in Asia that included the startup of three new satellite plants in 2025, the doubling of capacity at an existing satellite, and the expected commissioning of an additional new satellite in early 2026. These investments underscore MTI’s commitment to growth across markets and to helping customers cost-effectively produce high-quality products, improve productivity, and drive sustainable practices. MTI’s paper and packaging satellite...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (NYSE:VIRT), a leading provider of global, multi-asset financial services that delivers liquidity and innovative, transparent products across the complete investment cycle to the global markets, will announce its results for the fourth quarter of 2025 on Thursday, January 29, 2026, before the US market open. Virtu will host a conference call to discuss the company’s financial results at 8:00 AM (ET). A live webcast of the event will be available and archived on the Investor Relations section of the company’s website at https://ir.virtu.com/events-presentations. The call will be open to the public. About Virtu Financial, Inc.Virtu is a leading provider of financial services and products that leverages cutting-edge technology to deliver liquidity to the...

Karri AlameriOmaSp:n toimitusjohtaja Karri AlameriJaakko OssaOmaSp:n hallituksen puheenjohtaja Jaakko OssaOmaSp konttoriOmaSp konttori TurkuOMA SAVINGS BANK PLC STOCK EXCHANGE RELEASE, 14 JANUARY 2026 AT 16.20 P.M. EET, OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE Oma Savings Bank Plc’s Growth Strategy for 2026–2029 The Board of Directors of Oma Savings Bank Plc (“OmaSp” or the “Company”) has approved the Company’s strategy and financial targets for the 2026–2029 period. The goal of the strategy is to grow the Company responsibly and profitably, utilising personalised service as a competitive advantage. OmaSp focuses on retail customers and the SME sector. New financial targets for 2026–2029:Comparable ROE: over 14% Comparable cost-to-income ratio: below 50% Annual growth in fee and commission...

Access the segment here SOUTH SAN FRANCISCO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it participated in a Virtual Investor CEO Connect Segment. As part of the segment, Timothy Lu, MD, PhD, CEO of Senti, discussed its recent news release announcing that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to SENTI-202, the Company’s potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural killer (CAR-NK) investigational cell therapy, that is currently in development for the treatment of relapsed/refractory hematologic malignancies, including...

Company Achieves Record ARR in December, Representing a 300% Increase Over the Past 12 Months Fort Lauderdale, FL, Jan. 14, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – a leading AI technology company, announced today that achieved an annualized revenue run rate (“ARR”) of $9.7 million during December 2025, representing a 300% increase over the $2.5 million ARR that the company reached at the end of 2024. During 2025, SemiCab achieved five new contract wins with some of the largest multinational fast moving consumer goods companies (FMCGs) in India and was awarded seven contract expansions for increased lanes and trip volume. SemiCab is taking an increasing share of what is an enormous total addressable market.Current Clients & Market Coverage: In the Indian metropolitan regions SemiCab...

HERNDON, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) will host an audio webcast to review its 2025 fourth quarter and year-end financial results on Wednesday, Jan. 28, 2026, at 8:00 a.m. Eastern Time. The webcast will be available on Navient.com/investors; a replay of the webcast will be available on the site. The results and presentations slides will be available the same day by 7:00 a.m. on Navient.com/investors. In addition to being available on the company’s investor website, the results will be filed with the SEC on a Form 8-K available at SEC.gov. About NavientNavient (Nasdaq: NAVI) creates long-term value for customers and investors with responsible lending, flexible refinancing, trusted servicing oversight, and decades of education finance and portfolio management expertise. Through our Earnest business,...

Las Vegas, NV, Jan. 14, 2026 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced that the parties have extended the outside date of the merger agreement between flyExclusive, Inc. (NYSE American: FLYX) (“flyExclusive”) and Jet.AI to April 30th, 2026, with closing expected in the first quarter of 2026. “We’re excited about the deal and remain firmly committed,” said Jet.AI Founder and Executive Chairman Mike Winston.” flyExclusive’s Founder and Chief Executive Officer, Jim Segrave added: “We remain enthusiastically committed to the deal.” About Jet.AI Jet.AI Inc. is a technology-driven company focused on deploying artificial intelligence tools and infrastructure to enhance...

First data on blood-based mRNA signature for pancreatic ductal adenocarcinoma (PDAC) detection and intraductal papillary mucinous neoplasms (IPMN) differentiation to be presented in San Diego BERKELEY, Calif. and , Jan. 14, 2026 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, is excited to announce its participation in the upcoming American Association for Cancer Research (AACR) 2026 Annual Meeting. This prestigious conference will be held April 17 to 22, 2026, in San Diego, California. Organized by the American Association for Cancer Research, this premier event gathers scientists, clinicians, and industry leaders from around the world to share groundbreaking cancer research and explore new approaches in oncology. At AACR the Company will...